We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Medicinal Shrub Shows Potent Anti-Alzheimer's Disease Potential

By LabMedica International staff writers
Posted on 03 Jul 2017
Print article
Extracts from stem, leaves, and root of the African medicinal shrub Carpolobia lutea were found to possess inhibitors of the enzyme acetylcholinesterase (AChE) and antioxidants, which indicate potential for development as a treatment of Alzheimer’s disease (AD) and other disorders characterized by a cholinergic deficit.

Carpolobia lutea, known more commonly as cattle stick, is a small shrub or tree native to Central and West Africa. Herbalists in Nigerian tribes have used the essence of the root as an aphrodisiac and for treatment of genitourinary infections, gingivitis, and waist pains.

Investigators at the University of Nottingham (United Kingdom) scrutinized extracts and fractions of the stem, leaves, and roots of C. lutea for therapeutic promise as an AD treatment via their ability to inhibit AChE. Additionally, extracts and fractions were examined for radical scavenging and reducing (antioxidant) activities, polyphenol and flavonoid content, and C. lutea cytotoxicity.

The study was carried out through sequential solvent extractions of plant stem, leaves, and roots. The extracts were screened for anti-AChE activity across a concentration range of 0.02-200 micrograms per milliliter. Plant DPPH (2,2-diphenyl-1-picrylhydrazyl) radical scavenging activity, reducing power, and total phenolic and flavonoid contents were determined, and cytotoxicity evaluated using human hepatocytes.

Results published in the June 19, 2017, online edition of the journal Pharmaceutical Biology revealed that C. lutea exhibited concentration-dependent anti-AChE activity. The most potent inhibitory activity for the stem was the crude ethanol extract and hexane stem fraction oil; for the leaves, the chloroform leaf fraction; and for roots, the methanol, ethyl acetate, and aqueous root fractions. Dose-dependent free radical scavenging activity and reducing power were observed with increasing stem, leaf, or root concentration. Total phenolic contents were highest in the stem, while total flavonoid content was highest in the leaves. At one microgram per milliliter only the crude ethanol extract oil was significantly cytotoxic to hepatocytes.

Considering the plant's anti-AChE activity and its beneficial antioxidant capacity, the investigators concluded that it had considerable potential for development as a treatment of Alzheimer’s and other diseases characterized by a cholinergic deficiency.

Senior author Dr. Wayne Carter, lecturer and research group leader in the school of medicine at the University of Nottingham, said, "As a population we are living longer and the number of people with dementia is growing at an alarming rate. Our findings suggest that traditional medicines will provide new chemicals able to temper Alzheimer's disease progression."

Related Links:
University of Nottingham

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Ultrasound-based duplex sonography combined with a new genetic testing procedure can identify clonal haematopoiesis (Photo courtesy of 123RF)

New Genetic Testing Procedure Combined With Ultrasound Detects High Cardiovascular Risk

A key interest area in cardiovascular research today is the impact of clonal hematopoiesis on cardiovascular diseases. Clonal hematopoiesis results from mutations in hematopoietic stem cells and may lead... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: Exosomes can be a promising biomarker for cellular rejection after organ transplant (Photo courtesy of Nicolas Primola/Shutterstock)

Diagnostic Blood Test for Cellular Rejection after Organ Transplant Could Replace Surgical Biopsies

Transplanted organs constantly face the risk of being rejected by the recipient's immune system which differentiates self from non-self using T cells and B cells. T cells are commonly associated with acute... Read more

Pathology

view channel
Image: The Aperio GT 450 DX has received US FDA 510(k) clearance (Photo courtesy of Leica Biosystems)

Use of DICOM Images for Pathology Diagnostics Marks Significant Step towards Standardization

Digital pathology is rapidly becoming a key aspect of modern healthcare, transforming the practice of pathology as laboratories worldwide adopt this advanced technology. Digital pathology systems allow... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.